What Was The Reason Behind Ocuphire Pharma (OCUP) Stock Increasing 16% Extended Session?
Following the release of peer-reviewed data, Ocuphire Pharma Inc. (NASDAQ: OCUP) shares were up 16.36% to trade at $2.49 at the time of the most recent check. Who published the data from the OCUP? The good outcomes in patients with night vision disturbances (NVD) from Ocuphire Pharma’s initial Phase 2 research assessing the safety and […]
